BrightSpring Health Services Inc (BTSG) is overvalued and Doximity Inc (DOCS) is fairly valued.
Against our estimates of intrinsic value, DOCS trades at the wider discount: a margin of safety of +0%, against -81% for BTSG.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 11.7% (average of 3 methods) values the shares at $31.17; the price of $56.55 is 81% above that value, and 69% of that value comes from beyond year five.
Leak Score 14/100 on 3 of 12 signals
Discounting its cash flows at 10.8% (average of 3 methods) values the shares at $26.62; the price of $26.51 sits right on that value, and 72% of that value comes from beyond year five.
Leak Score 59/100 on 3 of 12 signals
| Metric | BTSG | DOCS |
|---|---|---|
| Verdict | Overvalued | Fairly valued |
| Price | $56.55 | $26.51 |
| Intrinsic value | $31.17 | $26.62 |
| Margin of safety | -81% | +0% |
| Leak Score | 14/100 (3/12) | 59/100 (3/12) |
| Market cap | $11.2B | $4.7B |
| Revenue growth, 5 years | 18.3% | 25.5% |
| Operating margin | 3.7% | 30.6% |
| Net margin | 2.0% | 25.5% |
| Return on equity | 13.1% | 17.2% |
| Debt to equity | 1.17 | 0.01 |
| P/E | 42.2x | 31.4x |
| Forward P/E | 24.5x | 17.1x |
| P/B | 5.5x | 5.2x |